Anne-Sofie Lynnerup

Large‐scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels

K. D. Sørensen, T. Ørntoft, J. Lindberg, 2016, Molecular oncology.

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

K. D. Sørensen, T. Ørntoft, M. Borre, 2018, Clinical Epigenetics.

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer

K. D. Sørensen, M. Borre, S. Høyer, 2015, Clinical Epigenetics.

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

K. D. Sørensen, T. Ørntoft, M. Borre, 2018, Clinical Epigenetics.

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer

K. D. Sørensen, M. Borre, S. Høyer, 2015, Clinical Epigenetics.

Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure.

M. Borup, A. S. Andreasen, J. Laake, 2021, The New England journal of medicine.

Clinico-Pathological Characterization of Hereditary, Familial and Sporadic Prostate Cancer

M. Borre, Anne-Sofie Lynnerup, Diem Nguyen Bentzon, 2012 .

Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure

M. Borup, A. S. Andreasen, J. Laake, 2021, New England Journal of Medicine.